Table 2.
Characteristic | Total (N = 3822) | CVD 1-5 Y After Cancer Diagnosis | ||
---|---|---|---|---|
Yes (n = 1719) | No (n = 2103) | P Value | ||
Histologic type | 0.43 | |||
Papillary carcinoma | 3510 (91.8) | 1564 (91.0) | 1946 (92.5) | |
Anaplastic carcinoma | 6 (0.2) | 4 (0.2) | 2 (0.1) | |
Follicular carcinoma | 240 (6.3) | 118 (6.9) | 122 (5.8) | |
Medullary carcinoma | 49 (1.3) | 24 (1.4) | 25 (1.2) | |
Other | 17 (0.4) | 9 (0.5) | 8 (0.4) | |
Treatment | 0.40 | |||
Surgery only | 1790 (46.8) | 809 (47.1) | 981 (46.7) | |
Surgery and radiation | 2006 (52.5) | 895 (52.1) | 1111 (52.8) | |
Other | 26 (0.7) | 15 (0.9) | 11 (0.5) | |
TSH suppression therapy | 0.002 | |||
No | 2881 (75.4) | 1254 (73.0) | 1627 (77.4) | |
Yes | 941 (24.6) | 465 (27.0) | 476 (22.6) | |
CCI score at baseline | < 0.0001 | |||
0 | 1543 (40.4) | 247 (14.4) | 1296 (61.6) | |
≥1 | 2279 (59.6) | 1472 (85.6) | 807 (38.4) | |
No. of cancers | 0.17 | |||
1 | 3456 (90.4) | 1542 (89.7) | 1914 (91.0) | |
≥2 | 366 (9.6) | 177 (10.3) | 189 (9.0) |
Data presented as n (%).